Best abstract award

Trasis @SNMMI 2017

Congratulations to our R&D department for its work on the "High-Yield fully automated production of [18F] Fluorocholine at high activity on the AllinOne Synthesizer" which leads on this prestigious international award !

Most extensive choice of tracers

Most extensive choice of tracers

18F, 11C, 68Ga, 177Lu, 188Re, 64Cu -based tracers and peptides.

In routine production, in R&D or in clinical trials, you can produce and develop any new tracers on our synthesizers. There are no hardware or software-related barriers.

Learn more

FDG Quad

FDG Quad - Your asset for FDG production

As announced few weeks ago Trasis releases its FDG Quad process which enables to produce FDG with 4 back to back runs with the same yield (70 ± 3% ndc).

Products

Helping the medical community easily access new radiolabeled therapeutic and diagnostic substances.

Our nuclear medicine equipment includes automated synthesizers, dose dispensing systems, their shielding and accessories. We also develop customized synthetic methods and instruments adapted to the evolving needs of the radiochemistry industry.

Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.

See all products

About us

In a  nutshell: designer and manufacturer of radiopharma instruments, ISO 9001-certified company, medical device distributor, close to its customers and partners.

What makes us different: we consider our customers' performance as our own and we put everything in place to improve it.

Our strength:  every aspect of our products: design, manufacturing, commercial service, quality and support is under our full control. Our great multidisciplinary team makes this possible.

Our final goal: enable patients to have access to a wide range of radiotracers in the safest and most timely manner.

Read more

Innovating for nuclear medicine

We develop innovating equipment which enables safe manipulation and quick access to radiolabeled therapeutic and diagnostic substances.

Nuclear Medecine departements

Drug developers

Drug developers

Nuclear medicine departments

Drug manufacturers

Drug manufacturers

After sales services
After Sales services
Contact us
Mail US
support_trasis [at] trasis [dot] com
Create a ticket
MyTRASIS

News & Events

June 13, 2017

2017 SNMMI International Best Abstract Award for Trasis
Congratulations to our R&D department for its work on the "High-Yield fully automated production of [18F] Fluorocholine at high activity on the AllinOne Synthesizer" which leads on this prestigious international award !
SNMMI Trasis
June 10, 2017

Meet us at SNMMI 2017
Trasis will exhibit at the SNMMI 2017 at Denver. Meet us on booth n°675 at the Colorado convention Center on 10-14 June, 2017.
Meet us at the ISRS 2017
May 14, 2017

Trasis @ISRS 2017

Trasis will exhibit at the 22nd International Symposium on Radiopharmaceutical Sciences (ISRS) 2017 in Dresden.

Meet us on booth n°21 at the  International Congress Center Dresden on 14-19 May, 2017.

Scientific Publications

Key facts

>35
Global partners
>30
Approved or demonstrated tracers
90%
exposure reduction
10 Years
Extended warranty for dispensers